Polycomb group proteins in hematopoietic stem cell aging and malignancies

Karin Klauke, Gerald de Haan*

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    8 Citations (Scopus)

    Abstract

    Protection of the transcriptional "stemness" network is important to maintain a healthy hematopoietic stem cells (HSCs) compartment during the lifetime of the organism. Recent evidence shows that fundamental changes in the epigenetic status of HSCs might be one of the driving forces behind many age-related HSC changes and might pave the way for HSC malignant transformation and subsequent leukemia development, the incidence of which increases exponentially with age. Polycomb group (PcG) proteins are key epigenetic regulators of HSC cellular fate decisions and are often found to be misregulated in human hematopoietic malignancies. In this review, we speculate that PcG proteins balance HSC aging against the risk of developing cancer, since a disturbance in PcG genes and proteins affects several important cellular processes such as cell fate decisions, senescence, apoptosis, and DNA damage repair.

    Original languageEnglish
    Pages (from-to)11-23
    Number of pages13
    JournalInternational journal of hematology
    Volume94
    Issue number1
    DOIs
    Publication statusPublished - Jul-2011

    Keywords

    • Hematopoietic stem cells
    • Aging
    • Leukemia
    • Epigenetics
    • Polycomb
    • ACUTE MYELOID-LEUKEMIA
    • HISTONE METHYLTRANSFERASE ACTIVITY
    • TUMOR-SUPPRESSOR LOCUS
    • BONE-MARROW-CELLS
    • RNA-POLYMERASE-II
    • GROUP GENE RAE28
    • SELF-RENEWAL
    • PROGENITOR CELLS
    • X-INACTIVATION
    • DNA-DAMAGE

    Fingerprint

    Dive into the research topics of 'Polycomb group proteins in hematopoietic stem cell aging and malignancies'. Together they form a unique fingerprint.

    Cite this